Granules

Granules is a vertically integrated pharmaceutical manufacturing enterprise established in 1984. Headquartered in Cyberabad, Telangana, India, the company specializes in the production of high-quality Active Pharmaceutical Ingredients (API), Finished Dosages (FD), Pharmaceutical Formulation Intermediates (PFI), and various specialty products. By maintaining a vertically integrated business model, Granules ensures rigorous quality control and supply chain efficiency across its global operations. The firm operates with a workforce of 1,000-5,000 employees and maintains a physical footprint across 8 distinct locations, supporting its B2B and B2C market strategies.

The company’s technical infrastructure supports large-scale manufacturing capabilities, enabling it to serve diverse healthcare markets effectively. Granules leverages advanced engineering and scientific expertise, with over 100 scientists and 250 engineering and technical professionals dedicated to product innovation and process optimization. This technical depth allows the organization to maintain competitive positioning within the global pharmaceutical sector, adhering to stringent regulatory standards while scaling production to meet international demand. With annual revenue reaching $562.4M, the company demonstrates significant market presence and operational stability.

Organizational leadership remains a core component of the company’s operational success. Meet Granules's team to understand the strategic direction and management structure driving the firm’s growth. With a focus on customer-centricity and operational excellence, Granules continues to expand its influence in the pharmaceutical industry. The company’s commitment to professional development and technical rigor ensures sustained performance in a complex, highly regulated global market environment, solidifying its status as a key player in the healthcare manufacturing landscape.